5-hydroxydecanoate has been researched along with rosiglitazone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Greyson, CR; Lu, L; Reiter, MJ; Sarraf, M; Schwartz, GG; Ye, S | 1 |
1 other study(ies) available for 5-hydroxydecanoate and rosiglitazone
Article | Year |
---|---|
Thiazolidinedione drugs promote onset, alter characteristics, and increase mortality of ischemic ventricular fibrillation in pigs.
Topics: Animals; Anti-Arrhythmia Agents; Coronary Vessels; Death, Sudden, Cardiac; Decanoic Acids; Female; Glyburide; Hydroxy Acids; Hypoglycemic Agents; Ischemia; Ischemic Preconditioning, Myocardial; Male; Pioglitazone; Potassium Channel Blockers; Rosiglitazone; Swine; Thiazolidinediones; Ventricular Fibrillation | 2012 |